0001209191-17-049934.txt : 20170823
0001209191-17-049934.hdr.sgml : 20170823
20170823161813
ACCESSION NUMBER: 0001209191-17-049934
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170821
FILED AS OF DATE: 20170823
DATE AS OF CHANGE: 20170823
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cooper Ronald Harold Wilfred
CENTRAL INDEX KEY: 0001676880
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33451
FILM NUMBER: 171047294
MAIL ADDRESS:
STREET 1: C/O GENOCEA BIOSCIENCES, INC.
STREET 2: 100 ACORN PARK DRIVE, 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALBIREO PHARMA, INC.
CENTRAL INDEX KEY: 0001322505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-415-4774
MAIL ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Biodel Inc
DATE OF NAME CHANGE: 20050331
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-08-21
0
0001322505
ALBIREO PHARMA, INC.
ALBO
0001676880
Cooper Ronald Harold Wilfred
C/O ALBIREO PHARMA INC.
10 POST OFFICE SQUARE, SUITE 502 SOUTH
BOSTON
MA
02109
1
1
0
0
President and CEO
Stock Option (right to buy)
24.48
2017-08-21
4
A
0
60000
0.00
A
2027-08-20
Common Stock
60000
60000
D
This option will vest and become exercisable in equal installments on the last day of 16 consecutive calendar quarters beginning with September 30, 2017 and ending on June 30, 2021.
/s/ Peter A. Zorn, Attorney-in-fact for Ronald H.W. Cooper
2017-08-23